Zopiclone. An update of its pharmacology, clinical efficacy and tolerability in the treatment of insomnia.
暂无分享,去创建一个
H. Lamb | S. Noble | H D Langtry | S Noble | H M Lamb | H. Langtry
[1] B. Virón,et al. Steady state pharmacokinetics of zopiclone during multiple oral dosing (7.5 mg nocte) in patients with severe chronic renal failure. , 1990, International clinical psychopharmacology.
[2] I. Hindmarch,et al. A comparison of the efficacy, tolerance and residual effects of zopiclone, flurazepam and placebo in insomniac outpatients. , 1990, International clinical psychopharmacology.
[3] E. Rüther,et al. Zopiclone improves sleep quality and daytime well‐being in insomniac patients: comparison with triazolam, flunitrazepam and placebo , 1994, International clinical psychopharmacology.
[4] J. Backman,et al. The effect of erythromycin on the pharmacokinetics and pharmacodynamics of zopiclone. , 1994, British journal of clinical pharmacology.
[5] J. Röschke,et al. Acute, subchronic and discontinuation effects of zopiclone on sleep EEG and nocturnal melatonin secretion , 1996, European Neuropsychopharmacology.
[6] H. Ashton. Guidelines for the rational use of benzodiazepines. When and what to use. , 1994, Drugs.
[7] Y. Løyning,et al. Effects of hypnotics on memory. , 1983, Pharmacology.
[8] M. Kato,et al. Relationship between the effects of a hypnotic drug, zopiclone, on polysomnography and on daytime EEGs. , 1997, Neuropsychobiology.
[9] H. Kazamatsuri,et al. Effects of zopiclone, flunitrazepam, triazolam and levomepromazine on the transient change in sleep-wake schedule: polygraphic study, and the evaluation of sleep and daytime condition. , 1993, Progress in neuro-psychopharmacology & biological psychiatry.
[10] M. Terzano,et al. Multidrug comparison (lorazepam, triazolam, zolpidem, and zopiclone) in situational insomnia: polysomnographic analysis by means of the cyclic alternating pattern. , 1997, Clinical neuropharmacology.
[11] D. Sherman,et al. Withdrawal from benzodiazepines by initially switching to zopiclone , 1995, European Psychiatry.
[12] A. Mcbride,et al. Zopiclone abuse in South Wales: Three case reports , 1995 .
[13] R. Élie,et al. Efficacy and safety of zopiclone and triazolam in the treatment of geriatric insomniacs. , 1990, International clinical psychopharmacology.
[14] M. Kurachi,et al. Comparison of the effect of zopiclone and brotizolam on sleep EEG by quantitative evaluation in healthy young women. , 1993, Sleep.
[15] Kiyoshi Kubota,et al. PEM report number 10. Zopiclone , 1993 .
[16] P. Neuvonen,et al. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of zopiclone , 1996, European Journal of Clinical Pharmacology.
[17] D. Pounder,et al. Zopiclone poisoning: tissue distribution and potential for postmortem diffusion. , 1994, Forensic science international.
[18] D. Monti,et al. Pharmacological Treatment of Chronic Insomnia , 1995 .
[19] D. McClure,et al. A comparison of the efficacy, safety and withdrawal effects of zopiclone and triazolam in the treatment of insomnia. , 1990, International clinical psychopharmacology.
[20] J. Bourgouin,et al. Comparison of zopiclone and flurazepam treatments in insomnia , 1990 .
[21] A. Besset,et al. Dose-response effects of zopiclone on night sleep and on nighttime and daytime functioning. , 1987, Sleep.
[22] C. Joyce,et al. Zopiclone, sleep and health‐related quality of life , 1994 .
[23] P. Paronen,et al. Interactions and comparative effects of zopiclone, diazepam and lorazepam on psychomotor performance and on elimination pharmacokinetics in healthy volunteers. , 1992, Acta Pharmacologica et Toxicologica.
[24] P. Blin,et al. Postmarketing surveillance of zopiclone in insomnia: analysis of 20,513 cases. , 1991, Sleep.
[25] R. Meatherall. Zopiclone fatality in a hospitalized patient. , 1997, Journal of forensic sciences.
[26] J. O'Donnell,et al. A comparative study of zopiclone and triazolam in patients with insomnia. , 1990, International Clinical Psychopharmacology.
[27] J. Gaillot,et al. Pharmacokinetics and metabolism of zopiclone. , 1983, Pharmacology.
[28] R. Élie,et al. Zopiclone versus Flurazepam in Insomnia: Prolonged Administration and Withdrawal , 1990, International clinical psychopharmacology.
[29] A. Patat,et al. Comparative study of the effects of zopiclone (7.5 mg), zolpidem, flunitrazepam and a placebo on nocturnal cognitive performance in healthy subjects, in relation to pharmacokinetics , 1995, European Psychiatry.
[30] J. Hoehns,et al. Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia. , 1993, Clinical pharmacy.
[31] K. Goa,et al. Zopiclone , 1986, Drugs.
[32] S. Russell,et al. Two cases of fatal zopiclone overdose. , 1996, Journal of Analytical Toxicology.
[33] Carmen Alvarez,et al. Hypnotic Drug Use in Spain: A Cross-Sectional Study Based on a Network of Community Pharmacies , 1996, The Annals of pharmacotherapy.
[34] J. Tytgat,et al. Detection and quantification of the hypnotic zopiclone, connected with an uncommon case of drowning. , 1996, Forensic science international.
[35] M. Ohayon,et al. Psychotropic Medication and Insomnia Complaints in Two Epidemiological Studies , 1996, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[36] P. Benfield,et al. Zolpidem , 1990, Drugs.
[37] K. Olkkola,et al. Pharmacokinetic-pharmacodynamic modelling of zopiclone effects on human central nervous system. , 1996, Pharmacology & toxicology.
[38] M. Bianchi,et al. Zopiclone versus triazolam in insomniac geriatric patients: a specific increase in delta sleep with zopiclone. , 1990, International clinical psychopharmacology.
[39] T. Tamminen,et al. Chronic administration of zopiclone and nitrazepam in the treatment of insomnia. , 1987, Sleep.
[40] M. Mattila,et al. Actions of zopiclone and carbamazepine, alone and in combination, on human skilled performance in laboratory and clinical tests. , 1990, British Journal of Clinical Pharmacology.
[41] R. Farinotti,et al. Clinical Pharmacokinetics of Zopiclone , 1995, Clinical pharmacokinetics.
[42] D. Kupfer,et al. Management of insomnia. , 1997, The New England journal of medicine.
[43] N. Kajimura,et al. A quantitative sleep-EEG study on the effects of benzodiazepine and zopiclone in schizophrenic patients , 1995, Schizophrenia Research.
[44] T. Dinan,et al. Physical dependence following zopiclone usage: A case report , 1992 .
[45] A. Anderson. Zopiclone and nitrazepam: a multicenter placebo controlled comparative study of efficacy and tolerance in insomniac patients in general practice. , 1987, Sleep.
[46] S. Ruben,et al. Zopiclone abuse among polydrug users. , 1996, Addiction.
[47] P. du Souich,et al. Pharmacokinetic and clinical parameters of zopiclone and trimipramine when administered simultaneously to volunteers. , 1984, Biopharmaceutics & drug disposition.
[48] G. Pons,et al. Excretion of Psychoactive Drugs into Breast Milk , 1994, Clinical pharmacokinetics.
[49] Å. Rundgren,et al. Double-blind comparison of zopiclone and flunitrazepam in elderly insomniacs with special focus on residual effects. , 1995, Current medical research and opinion.
[50] I. Matheson,et al. The excretion of zopiclone into breast milk. , 1990, British Journal of Clinical Pharmacology.
[51] A. Broadhurst,et al. Residual effects of zopiclone (Imovane). , 1987, Sleep.
[52] C. Shapiro,et al. The socioeconomic impact of insomnia. An overview. , 1996, PharmacoEconomics.
[53] M. Mattila,et al. Actions and interactions of hypnotics on human performance: single doses of zopiclone, triazolam and alcohol. , 1990, International clinical psychopharmacology.
[54] R. Farinotti,et al. Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers. , 1993, Drug metabolism and disposition: the biological fate of chemicals.
[55] M. Bianchi,et al. Zopiclone discontinuation: review of 25 studies assessing withdrawal and rebound phenomena. , 1990, International clinical psychopharmacology.
[56] J. Pecknold,et al. Long term efficacy and withdrawal of zopiclone: a sleep laboratory study. , 1990, International clinical psychopharmacology.
[57] N. Uchimura,et al. Effects of Zopiclone on Slow Wave Sleep and Spontaneous K‐complexes for Normal Healthy Young Adults , 1993, The Japanese journal of psychiatry and neurology.
[58] J. Walsh,et al. Avoiding the blanket approach to insomnia. Targeted therapy for specific causes. , 1991, Postgraduate medicine.
[59] J. Brun. Zopiclone, a cyclopyrrolone hypnotic: Review of properties , 1988, Pharmacology, Biochemistry and Behavior.
[60] I. Hindmarch,et al. The effect of zopiclone 7.5 mg on the sleep, mood and performance of shift workers. , 1990, International clinical psychopharmacology.
[61] J. Dreyfus,et al. Zopiclone versus nitrazepam: a double-blind comparative study of efficacy and tolerance in elderly patients with chronic insomnia. , 1987, Sleep.
[62] Y. Le Roux,et al. Critical factors for pharmacokinetics of zopiclone in the elderly and in patients with liver and renal insufficiency. , 1987, Sleep.
[63] P. Neuvonen,et al. Concentrations and effects of zopiclone are greatly reduced by rifampicin. , 1997, British journal of clinical pharmacology.
[64] G. Biggio,et al. Failure of long‐term administration of zopiclone and zolpidem to induce tolerance in mice , 1996 .
[65] C Cotrel,et al. The pharmacology of cyclopyrrolone derivatives acting at the GABAA/benzodiazepine receptor. , 1992, Advances in biochemical psychopharmacology.
[66] P. Lemoine,et al. Gradual withdrawal of zopiclone (7.5 mg) and zolpidem (10 mg) in insomniacs treated for at least 3 months , 1995, European psychiatry.
[67] J. Fleming,et al. A Sleep Laboratory Evaluation of the Long-Term Efficacy of Zopiclone , 1988, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[68] G. Bensimon,et al. COMPARATIVE EFFECTS OF ZOPICLONE, TRIAZOLAM AND PLACEBO ON MEMORY AND PSYCHOMOTOR PERFORMANCE IN HEALTHY VOLUNTEERS , 1987, Fundamental & clinical pharmacology.